Commentary
Opinion
Artificial intelligence in your office
Some AI-based tools are available to use in your office right now, with no “existential” threat to anybody.
Commentary
Disenfranchised grief: What it looks like, where it goes
Disenfranchised grief, the grief that is hard to share and often seems wrong to feel in the first place, can be triggered in many situations.
Commentary
Mammography breast density reporting: What it means for clinicians
Should this be something that we talk to patients about, utilizing shared decision-making to decide about whether follow-up testing is necessary...
Commentary
Really? Cancer screening doesn’t save lives?
The screening tests are unlikely to help most people because most people will not die of the particular type of cancer being screened for. But it...
Commentary
Cruel summer for medical students and Taylor Swift fans
Medical students applying for residency tend to be as stressed out as Swifties trying to score concert tickets.
Commentary
More expensive alcohol saves lives. Will it affect cancer?
What was also interesting was that the benefits were confined to the lower socioeconomic classes.
Commentary
Considering the true costs of clinical trials
There are many subtle and some egregious ways that participating in clinical trials can result in increased costs.
Commentary
The best CRC screening test is still this one
Both the AAFP and the ACP question the lowering of the age for first colonoscopy.
Commentary
For NSCLC, neoadjuvant, adjuvant, or both?
I think it’s a great place for shared decision-making because if a patient hears about that and decides they’re not interested, I’ll be fine with...
Commentary
Prior auth is a self-inflicted wound; is there a way out?
As costs continue to rise uncontrollably, the prior authorization system has ballooned out of control and reining in this system will be quite a...
Commentary
Who owns your genes?
The assumption of any sane person would be that he or she owns his or her own genes. I mean, how dumb a question is that?